rs143175221
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_000410.4(HFE):āc.884T>Cā(p.Val295Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000417 in 1,614,014 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000410.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HFE | NM_000410.4 | c.884T>C | p.Val295Ala | missense_variant | 4/6 | ENST00000357618.10 | NP_000401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HFE | ENST00000357618.10 | c.884T>C | p.Val295Ala | missense_variant | 4/6 | 1 | NM_000410.4 | ENSP00000417404.1 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152186Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000841 AC: 211AN: 251032Hom.: 0 AF XY: 0.000899 AC XY: 122AN XY: 135756
GnomAD4 exome AF: 0.000397 AC: 581AN: 1461710Hom.: 1 Cov.: 34 AF XY: 0.000459 AC XY: 334AN XY: 727164
GnomAD4 genome AF: 0.000604 AC: 92AN: 152304Hom.: 1 Cov.: 31 AF XY: 0.000752 AC XY: 56AN XY: 74470
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 10, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 09, 2020 | This variant is associated with the following publications: (PMID: 19787796, 22624560, 24872867, 15046077, 12542741, 26456104) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | HFE: BP4 - |
Hemochromatosis type 1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The missense variant c.884T>C(p.Val295Ala) in HFE gene has been reported in heterozygous state in individuals with Hemochromatosis (Barton JC et. al., 2015; Malekzadeh MM et. al., 2014; Jones DC et. al., 2002). Functional studies reporting the observed variant along with another variant (c.829G>A) of HFE gene reveals that both mutations may play a role in the development of Hereditary haemochromatosis (Silva B et. al., 2012). The observed variant has allele frequency of 0.08% in gnomAD exomes database. This variant has been reported to the ClinVar database as Likely benign / Uncertain Significance. Multiple lines of computational evidence (Polyphen - Benign, SIFT - Tolerated and MutationTaster - Polymorphism) predict no damaging effect on protein structure and function for this variant. The amino acid Val at position 295 is changed to a Ala changing protein sequence and it might alter its composition and physico-chemical properties. However, additional functional studies will be required to confirm the pathogencity of the variant. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS). In the absence of another reportable variant in HFE gene, the molecular diagnosis is not confirmed. - |
HFE-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary hemochromatosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at